Upgrade to SI Premium - Free Trial

GlucoTrack (GCTK)

2.98 -0.34 (10.24%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (9/25/26 *Est.)

Latest Headlines

Form 8-K Glucotrack, Inc. For: Aug 28 August 28, 2026 5:15 PM - SEC Filing Form 425 Glucotrack, Inc. Filed by: Glucotrack, Inc. August 28, 2026 4:33 PM - SEC Filing Form 8-K/A Glucotrack, Inc. For: Jul 09 August 28, 2026 4:29 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Aug 27 August 27, 2026 8:45 AM - SEC Filing Glucotrack announces 1-for-15 reverse stock split effective Aug. 31 August 27, 2026 8:01 AM - StreetInsider Glucotrack, Inc. Announces Reverse Stock Split August 27, 2026 8:00 AM - BizWire Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100 August 25, 2026 8:00 AM - BizWire Form DEFA14A Glucotrack, Inc. August 21, 2026 4:06 PM - SEC Filing Lokahi Therapeutics renews University of Georgia academic program tie August 21, 2026 8:00 AM - StreetInsider Lōkahi Therapeutics™ Expands ai² Futures Lab™ Asset Origination Network Through Continued Collaboration with the University of Georgia August 21, 2026 8:00 AM - BizWire Form 8-K Glucotrack, Inc. For: Aug 18 August 19, 2026 9:01 AM - SEC Filing Glucotrack regains Nasdaq compliance with stockholders' equity rule August 17, 2026 8:00 AM - StreetInsider Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation August 17, 2026 8:00 AM - BizWire Form 10-Q Glucotrack, Inc. For: Jun 30 August 14, 2026 4:12 PM - SEC Filing Form DEF 14A Glucotrack, Inc. For: Aug 10 August 10, 2026 5:33 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Aug 07 August 10, 2026 4:06 PM - SEC Filing E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack August 6, 2026 8:15 AM - Globe NewsWire E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack August 6, 2026 8:15 AM - StreetInsider Form 8-K Glucotrack, Inc. For: Aug 04 August 5, 2026 5:21 PM - SEC Filing Glucotrack Announces $5.5 Million Financing August 5, 2026 8:30 AM - BizWire CORRECTING and REPLACING Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline August 3, 2026 8:49 AM - BizWire Form PRE 14A Glucotrack, Inc. For: Jul 31 July 31, 2026 5:07 PM - SEC Filing Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline July 31, 2026 8:00 AM - BizWire Form 8-K Glucotrack, Inc. For: Jul 29 July 30, 2026 5:29 PM - SEC Filing Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration July 29, 2026 5:30 PM - BizWire Form 8-K/A Glucotrack, Inc. For: Jul 22 July 29, 2026 5:15 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Jul 22 July 27, 2026 4:30 PM - SEC Filing Form ARS Glucotrack, Inc. For: Dec 31 July 17, 2026 5:00 PM - SEC Filing Form DEF 14A Glucotrack, Inc. For: Jul 17 July 17, 2026 4:46 PM - SEC Filing E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Conve July 17, 2026 1:21 PM - StreetInsider E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million C July 17, 2026 1:20 PM - Globe NewsWire Glucotrack completes bridge financing after Lōkahi merger July 17, 2026 8:06 AM - StreetInsider Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets July 17, 2026 8:05 AM - Globe NewsWire Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Ini July 17, 2026 8:05 AM - StreetInsider Glucotrack completes merger with Lōkahi Therapeutics, ceding control July 16, 2026 4:58 PM - StreetInsider UPDATE – Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform July 16, 2026 4:57 PM - StreetInsider Form 425 Glucotrack, Inc. Filed by: Glucotrack, Inc. July 15, 2026 5:21 PM - SEC Filing Form 8-K Glucotrack, Inc. For: Jul 09 July 15, 2026 5:20 PM - SEC Filing Glucotrack and Lōkahi Therapeutics Complete Strategic Business Combination, Establishing Lōkahi-Controlled Public Platform July 14, 2026 5:40 PM - Globe NewsWire USPTO allows Glucotrack patent for implantable glucose monitor July 8, 2026 8:00 AM - StreetInsider Glucotrack Announces USPTO Notice of Allowance for Patent Application Covering Its Implantable CBGM Platform July 8, 2026 8:00 AM - StreetInsider Form PRE 14A Glucotrack, Inc. For: Jun 17 June 17, 2026 5:03 PM - SEC Filing Full Article List